OQROGet OQRO Pro
Insider trade

Ligand Pharmaceuticals, Inc. (LGND)Director sold ~$117K

John W Kozarich, Director at Ligand Pharmaceuticals, Inc., sold ~$117K of Ligand Pharmaceuticals, Inc. shares.

~$117K
Approx. value · 934 sh @ $125.00
46K
Holds after · shares reported
Traded
Jul 10, 2025
Filed
Jul 11, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 9, 2025Insider · 1 personInsiders: 3 purchases (~$1.0M)
  2. May 15, 2025InsiderOfficer sold ~$104K of LGND shares in the open market
  3. Jun 10, 2025InsiderOfficer sold ~$57K of LGND shares in the open market
  4. Jun 23, 2025InsiderOfficer sold ~$57K of LGND shares in the open market
  5. Jul 10, 2025 · this disclosureInsiderDirector sold ~$117K of LGND shares in the open market

What came next

  1. Aug 1, 2025InsiderDirector sold ~$62K of LGND shares in the open market
  2. Sep 2, 2025Insider · 1 personInsiders: 3 sales (~$76K)
  3. Sep 12, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  4. Sep 23, 2025Insider · 1 personInsiders: 3 sales (~$1.7M)
  5. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ligand Pharmaceuticals, Inc.

For Ligand Pharmaceuticals, Inc., OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LGND page.

Other recent filings by John W Kozarich, Director

The full history of John W Kozarich, Director is on the profile page.

How this filing works

Other disclosures at Ligand Pharmaceuticals, Inc.

Everything OQRO holds on this company is on its LGND page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data